 |
|
Gene mutation increases drug toxicity, rejection risk in pediatric kidney transplants
February 18, 2009Study suggests genetic approach to personalized screening, drug dosing
CINCINNATI - Screening for mutations in a gene that helps the body metabolize a kidney transplant anti-rejection drug may predict which children are at higher risk for side effects, including compromised white blood cell count or organ rejection, according to new research.
Published online Feb. 18 by the Nature journal Clinical Pharmacology and Therapeutics, the study suggests this genetic approach could also help physicians tailor personalized anti-rejection drug doses to prevent adverse reactions, said senior investigators Alexander A. Vinks, Pharm.D., Ph.D., and Jens Goebel M.D., of Cincinnati Children's Hospital Medical Center.
"There are better ways than just giving standard doses of these drugs, and in due course these types of technologies will be available worldwide to help patients," said Dr. Vinks, director of the Division of Clinical Pharmacology and the Pediatric Pharmacology Research Unit at Cincinnati Children's. "This pilot study shows personalized and prospective MMF dosing and monitoring may be feasible to reduce the high incidence of drug toxicity in children without compromising the drug's protective effects against kidney graft rejection."
MMF, or Mycophenolate Mofetil, is an immunosuppressive agent commonly used to prevent rejection in organ transplants, particularly in kidney transplants. After taken orally, the drug is quickly processed by the body into active form. During this time, patients with a specific point mutation in the gene that helps break down the drug, UGT, metabolize the drug slower. This point mutation, called UGT1A9-331, causes overexposure and adverse side effects in the affected children, the study concluded. UGT encodes the drug's main metabolizing enzyme in the body, uridine diphosphate-glucuronosyl transferase.
Adverse side effects most commonly linked to MMF have included gastrointestinal complications (such as diarrhea) or leukopenia - a drop in white blood cell count that can put patients at higher risk for infections. In some instances, patients have to be taken off the drug or have their dosage reduced to the point where they risk rejection of the new organ.
The current study analyzed 38 children who had received kidney transplants. Sixteen of the children experienced adverse side effects from MMF therapy. In the adverse reaction group, nine children with the specific UGT point mutation developed leukopenia. The researchers found no strong association between UGT gene variants and diarrhea - the most common side effect linked to MMF - suggesting gastrointestinal reactions to the drug may be caused by other factors.
Some previous studies have linked UGT gene mutations and MMF-related side effects in kidney transplant recipients, while others have suggested a greater risk for adverse events in children. A review of earlier research combined with their current data led researchers in this study to conclude that pediatric kidney transplant recipients on MMF therapy have a significantly higher likelihood of drug-related complications than adult patients. One previous study compared 22 pediatric and 37 adult transplant recipients, all who started with the standard recommended doses of MMF. Among the children, 54.5 percent experienced adverse side effects compared to 21.6 percent of the adults.
Besides the UGT1A9-331 point mutation, other studies have also linked a second variation, called UGT2B7-900, to possible MMF overexposure and development of leukopenia, said Tsuyoshi Fukuda, Ph.D., co-author on the current study and a colleague in Dr. Vinks' division at Cincinnati Children's. The research team recently completed pharmacokinetic and biomarker studies - which analyze how the body metabolizes a drug - to solidify the connection between different variants of UGT and MMF overexposure in pediatric kidney transplant patients.
Researchers want to use data from these pharmacokinetic studies as a basis for showing whether increased MMF exposure in adults can also be linked to specific variations in the UGT gene, according to Dr. Fukuda.
The pilot study is part of the growing field of genetic-based pharmacology, or pharmacogenetics. Combining biology and information technology, researchers are developing computer-based algorithms that allow taking a few drops of blood and analyzing how quickly a person's body will break down and absorb a drug based on their genetic makeup. The goal is to reduce drug-related side affects by optimizing drug doses for individual patients.
Cincinnati Children's Hospital Medical Center
"There are better ways than just giving standard doses of these drugs, and in due course these types of technologies will be available worldwide to help patients," said Dr. Vinks, director of the Division of Clinical Pharmacology and the Pediatric Pharmacology Research Unit at Cincinnati Children's. "This pilot study shows personalized and prospective MMF dosing and monitoring may be feasible to reduce the high incidence of drug toxicity in children without compromising the drug's protective effects against kidney graft rejection."
MMF, or Mycophenolate Mofetil, is an immunosuppressive agent commonly used to prevent rejection in organ transplants, particularly in kidney transplants. After taken orally, the drug is quickly processed by the body into active form. During this time, patients with a specific point mutation in the gene that helps break down the drug, UGT, metabolize the drug slower. This point mutation, called UGT1A9-331, causes overexposure and adverse side effects in the affected children, the study concluded. UGT encodes the drug's main metabolizing enzyme in the body, uridine diphosphate-glucuronosyl transferase.
Adverse side effects most commonly linked to MMF have included gastrointestinal complications (such as diarrhea) or leukopenia - a drop in white blood cell count that can put patients at higher risk for infections. In some instances, patients have to be taken off the drug or have their dosage reduced to the point where they risk rejection of the new organ.
The current study analyzed 38 children who had received kidney transplants. Sixteen of the children experienced adverse side effects from MMF therapy. In the adverse reaction group, nine children with the specific UGT point mutation developed leukopenia. The researchers found no strong association between UGT gene variants and diarrhea - the most common side effect linked to MMF - suggesting gastrointestinal reactions to the drug may be caused by other factors.
Some previous studies have linked UGT gene mutations and MMF-related side effects in kidney transplant recipients, while others have suggested a greater risk for adverse events in children. A review of earlier research combined with their current data led researchers in this study to conclude that pediatric kidney transplant recipients on MMF therapy have a significantly higher likelihood of drug-related complications than adult patients. One previous study compared 22 pediatric and 37 adult transplant recipients, all who started with the standard recommended doses of MMF. Among the children, 54.5 percent experienced adverse side effects compared to 21.6 percent of the adults.
Besides the UGT1A9-331 point mutation, other studies have also linked a second variation, called UGT2B7-900, to possible MMF overexposure and development of leukopenia, said Tsuyoshi Fukuda, Ph.D., co-author on the current study and a colleague in Dr. Vinks' division at Cincinnati Children's. The research team recently completed pharmacokinetic and biomarker studies - which analyze how the body metabolizes a drug - to solidify the connection between different variants of UGT and MMF overexposure in pediatric kidney transplant patients.
Researchers want to use data from these pharmacokinetic studies as a basis for showing whether increased MMF exposure in adults can also be linked to specific variations in the UGT gene, according to Dr. Fukuda.
The pilot study is part of the growing field of genetic-based pharmacology, or pharmacogenetics. Combining biology and information technology, researchers are developing computer-based algorithms that allow taking a few drops of blood and analyzing how quickly a person's body will break down and absorb a drug based on their genetic makeup. The goal is to reduce drug-related side affects by optimizing drug doses for individual patients.
Cincinnati Children's Hospital Medical Center
Kidney Transplants Current Events and Kidney Transplants News RSSKidney transplants generally safe for lupus patients
Individuals with a history of lupus who receive a kidney transplant rarely develop the serious inflammatory condition lupus nephritis in their new organ, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.
Affordable anti-rejection drug as effective as higher cost option
A newer, less expensive drug used to suppress the immune system and prevent organ rejection in kidney and pancreas transplant patients works just as well as its much more expensive counterpart, according to a new study by researchers at Wake Forest University Baptist Medical Center.
Strategy for mismatched stem cell transplants triggers protection against graft-vs.-host disease
A new technique being tested in stem-cell transplants from imperfectly matched donors has revealed a striking, unforeseen response that can suppress graft-versus-host disease, a common and dangerous complication of mismatched transplants, report scientists from Dana-Farber Cancer Institute.
Kidneys from deceased donors with acute renal failure expand donor pool
Kidneys recovered from deceased donors with acute renal failure (ARF) - once deemed unusable for transplant - appear to work just as well as kidneys transplanted from deceased donors who do not develop kidney problems prior to organ donation.
Rare genetic disease successfully reversed using stem cell transplantation
A recent study by Scripps Research Institute scientists offers good news for families of children afflicted with the rare genetic disorder, cystinosis.
Cardiac arrest casualties form a valuable source of donor kidneys
A pilot study of a system for harvesting kidneys from non-heart-beating donors where attempts of resuscitation after a witnessed out-of-hospital cardiac arrest have failed (uncontrolled NHBDs) resulted in 21 successful kidney transplants - a 10% increase in the transplantation rate - over 17 months.
Mars and Venus: Short- and long-term success of male to female kidney transplants
Female recipients of kidneys from deceased male donors demonstrate an increased risk of allograft failure in the first year after transplant, but show no increased risk after ten years.
Post-transplant combo can replace toxic immune-suppressing drugs in monkeys
Transplant patients rely on drugs to prevent graft rejection, but at the cost of serious side effects.
Transplant drug stimulates immune memory
Rapamycin, a drug given to transplant recipients to suppress their immune systems, has a paradoxical effect on cells responsible for immune memory, scientists at the Emory Vaccine Center have discovered.
'Nature vs. nurture' study of deceased donor pairs in kidney transplantation
The implications of a new study could improve the outcomes, and potentially survival rates, for some of the thousands of individuals who undergo kidney transplants each year.
More Kidney Transplants Current Events and Kidney Transplants News Articles
 |
Dropsy, Dialysis, Transplant: A Short History of Failing Kidneys (Johns Hopkins Biographies of Disease) by Steven J. Peitzman (Author) Small and bean shaped, the kidneys are sophisticated organs that filter waste from the blood. A number of diseases and disorders -- including diabetes and hypertension -- can harm the kidneys and cause them to fail. Historian and nephrologist Steven J. Peitzman traces the medical history of kidney disease alongside the personal experience of illness. Drawing on diaries, letters, literary narratives, and scientific writings, Peitzman charts the triumphs of medical innovators like Richard Bright, Thomas Addis, and Belding Scribner as well as the stories of persons, famous and not, who have struggled with the disease. Conditions once known as "Bright's Disease" are now recognized as complex disorders with names such as glomerulopathy and acute tubular necrosis. Treatments... |
 |
Kidney Transplants Explained by Andy Stein (Author) This book offers coverage of the important topics such as the 'postcode lottery', organ allocation and deceased and living donor organs. It provides practical information about the operation, medication and the first three months after transplant. It offers post-transplant advice: how to look after yourself and your new kidney. Real life accounts of people who have experienced the issues are discussed. All the 'Key Facts' are summarised at the end of each chapter. |
 |
Joseph E. Murray and the Story of the First Human Kidney Transplant (Unlocking the Secrets of Science) by Joanne Mattern (Author) The American doctor, Joseph E. Murray, whose research into organ transplant rejection led to the first successful kidney transplant. |
 |
Way of the Blood Drippers by KT Fung (Author) The story in this book, set principally in the nowadays United States, follows two secret agents, Peter Cushing from the United States and Tiffany Li from China, on their adventures to chase after building-leaping, dagger-throwing members of the ultra secret society, the Blood Drippers Clan, in their quest to quell a covert operation that employed unknowing X agents embedded within the United States to carry out deadly missions. Along the way, Peter and Tiffany had to deal with assassinations, deaths and incidents involving the use of radioactive materials as well as a fast-approaching deadline. |
 |
Kidney Transplant Survivor Kids Light T-Shirt by CafePress |
|
The inside story: A kid's guide to kidney and liver transplants by Karen Crowe (Author) | |
 |
Surgeons Conduct a Kidney Transplant Photographic Poster Print by Jodi Cobb, 24x18 by Art.com Art.com is the world's largest retailer of art prints, posters, photographs, and framed artwork. With our huge selection of over 400,000 prints, you'll easily find the perfect piece for your home, office, or classroom. Our art is printed on quality paper. When you order framed artwork, the piece is built by our team of in-house professionals. Visit our Amazon store today at www.amazon.com/artdotcom to find Special Offers and search for products based on 'Artist Name' and 'Subject Categories' such as Movie, Music, Vintage, TV, Children, Travel, Kitchen, Museum Art, Animals, Floral, Motivational, and Sports. Art.com is dedicated to providing you with high quality products and service by offering you 100% satisfaction guaranteed. We ship internationally to over 80 countries. Decorate your... |
 |
Kidney Transplant Survivor Infant/Toddler T-Shirt by CafePress |
 |
Organ Transplant: Making a Match (Home Use) Part of the award winning public television series Healthy Body/Healthy Mind. About sixty years ago, successful organ transplants for humans began to show signs of success. Since then, organ transplants have saved millions of lives worldwide. More than 65,000 Americans are waiting for an organ transplant. While each day about 57 Americans receive a transplant, about 13 will die because not enough organs are available. Once a transplant has been completed, preventing the body's rejection of the transplanted organ can be an ongoing challenge. The body's attempt to destroy the transplanted organ; usually occurs in the first year after transplant. Rejection occurs when the body tries to attack a transplanted organ because it reacts to the organ or tissue as a foreign object and produces... |
 |
Perfect Match: A Kidney Transplant Reveals the Ultimate Second Chance by Janet Hermans (Author) |
| © 2009 BrightSurf.com |